
The following have been reloaded with a version change:
  1) GCCcore/8.3.0 => GCCcore/9.3.0
  2) binutils/2.32-GCCcore-8.3.0 => binutils/2.34-GCCcore-9.3.0
  3) zlib/1.2.11-GCCcore-8.3.0 => zlib/1.2.11-GCCcore-9.3.0

2021-02-01 01:04:33 | INFO | fairseq_cli.train | Namespace(activation_dropout=0.0, activation_fn='relu', adam_betas='(0.9, 0.98)', adam_eps=1e-08, adaptive_input=False, adaptive_softmax_cutoff=None, adaptive_softmax_dropout=0, all_gather_list_size=16384, arch='transformer_vaswani_wmt_en_de_big', attention_dropout=0.0, best_checkpoint_metric='loss', bf16=False, bpe=None, broadcast_buffers=False, bucket_cap_mb=25, checkpoint_suffix='', clip_norm=0.0, cpu=False, criterion='label_smoothed_cross_entropy', cross_self_attention=False, curriculum=0, data='../../../data-bin/phrase_4_0.5_tag_EMEA', data_buffer_size=10, dataset_impl=None, ddp_backend='c10d', decoder_attention_heads=16, decoder_embed_dim=1024, decoder_embed_path=None, decoder_ffn_embed_dim=4096, decoder_input_dim=1024, decoder_layerdrop=0, decoder_layers=6, decoder_layers_to_keep=None, decoder_learned_pos=False, decoder_normalize_before=False, decoder_output_dim=1024, device_id=0, disable_validation=False, distributed_backend='nccl', distributed_init_method=None, distributed_no_spawn=False, distributed_port=-1, distributed_rank=0, distributed_world_size=1, distributed_wrapper='DDP', dropout=0.2, empty_cache_freq=0, encoder_attention_heads=16, encoder_embed_dim=1024, encoder_embed_path=None, encoder_ffn_embed_dim=8192, encoder_layerdrop=0, encoder_layers=6, encoder_layers_to_keep=None, encoder_learned_pos=False, encoder_normalize_before=False, eval_bleu=True, eval_bleu_args='{"beam": 5, "max_len_a": 1.2, "max_len_b": 10}', eval_bleu_detok='moses', eval_bleu_detok_args=None, eval_bleu_print_samples=True, eval_bleu_remove_bpe='@@ ', eval_tokenized_bleu=False, fast_stat_sync=False, find_unused_parameters=False, fix_batches_to_gpus=False, fixed_validation_seed=None, fp16=True, fp16_init_scale=128, fp16_no_flatten_grads=False, fp16_scale_tolerance=0.0, fp16_scale_window=None, keep_best_checkpoints=-1, keep_interval_updates=-1, keep_last_epochs=-1, label_smoothing=0.1, layernorm_embedding=False, left_pad_source='True', left_pad_target='False', load_alignments=False, localsgd_frequency=3, log_format=None, log_interval=100, lr=[0.000175], lr_scheduler='inverse_sqrt', max_epoch=20, max_sentences=None, max_sentences_valid=None, max_source_positions=1024, max_target_positions=1024, max_tokens=4096, max_tokens_valid=4096, max_update=0, maximize_best_checkpoint_metric=False, memory_efficient_bf16=False, memory_efficient_fp16=False, min_loss_scale=0.0001, min_lr=-1, model_parallel_size=1, no_cross_attention=False, no_epoch_checkpoints=True, no_last_checkpoints=False, no_progress_bar=False, no_save=False, no_save_optimizer_state=False, no_scale_embedding=False, no_seed_provided=True, no_token_positional_embeddings=False, nprocs_per_node=1, num_batch_buckets=0, num_workers=1, optimizer='adam', optimizer_overrides='{}', patience=-1, profile=False, quant_noise_pq=0, quant_noise_pq_block_size=8, quant_noise_scalar=0, quantization_config_path=None, required_batch_size_multiple=8, reset_dataloader=True, reset_lr_scheduler=False, reset_meters=False, reset_optimizer=True, restore_file='../../../models/wmt19.de-en.joined-dict.ensemble//model1.pt', save_dir='../checkpoints/EMEA_p_7', save_interval=1, save_interval_updates=0, scoring='bleu', seed=1, sentence_avg=False, share_all_embeddings=False, share_decoder_input_output_embed=True, skip_invalid_size_inputs_valid_test=False, slowmo_algorithm='LocalSGD', slowmo_momentum=None, source_lang=None, stop_time_hours=0, target_lang=None, task='translation', tensorboard_logdir='', threshold_loss_scale=None, tie_adaptive_weights=False, tokenizer=None, tpu=False, train_subset='train', truncate_source=False, update_freq=[1], upsample_primary=1, use_bmuf=False, use_old_adam=False, user_dir=None, valid_subset='valid', validate_after_updates=0, validate_interval=1, validate_interval_updates=0, warmup_init_lr=-1, warmup_updates=4000, weight_decay=1e-07)
2021-02-01 01:04:34 | INFO | fairseq.tasks.translation | [de] dictionary: 42024 types
2021-02-01 01:04:34 | INFO | fairseq.tasks.translation | [en] dictionary: 42024 types
2021-02-01 01:04:34 | INFO | fairseq.data.data_utils | loaded 151 examples from: ../../../data-bin/phrase_4_0.5_tag_EMEA/valid.de-en.de
2021-02-01 01:04:34 | INFO | fairseq.data.data_utils | loaded 151 examples from: ../../../data-bin/phrase_4_0.5_tag_EMEA/valid.de-en.en
2021-02-01 01:04:34 | INFO | fairseq.tasks.translation | ../../../data-bin/phrase_4_0.5_tag_EMEA valid de-en 151 examples
2021-02-01 01:04:37 | INFO | fairseq_cli.train | TransformerModel(
  (encoder): TransformerEncoder(
    (dropout_module): FairseqDropout()
    (embed_tokens): Embedding(42024, 1024, padding_idx=1)
    (embed_positions): SinusoidalPositionalEmbedding()
    (layers): ModuleList(
      (0): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (1): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (2): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (3): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (4): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (5): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
    )
  )
  (decoder): TransformerDecoder(
    (dropout_module): FairseqDropout()
    (embed_tokens): Embedding(42024, 1024, padding_idx=1)
    (embed_positions): SinusoidalPositionalEmbedding()
    (layers): ModuleList(
      (0): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (1): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (2): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (3): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (4): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (5): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
    )
    (output_projection): Linear(in_features=1024, out_features=42024, bias=False)
  )
)
2021-02-01 01:04:37 | INFO | fairseq_cli.train | model transformer_vaswani_wmt_en_de_big, criterion LabelSmoothedCrossEntropyCriterion
2021-02-01 01:04:37 | INFO | fairseq_cli.train | num. model params: 312778752 (num. trained: 312778752)
2021-02-01 01:04:41 | INFO | fairseq.trainer | detected shared parameter: decoder.embed_tokens.weight <- decoder.output_projection.weight
2021-02-01 01:04:41 | INFO | fairseq.utils | ***********************CUDA enviroments for all 1 workers***********************
2021-02-01 01:04:41 | INFO | fairseq.utils | rank   0: capabilities =  7.0  ; total memory = 32.000 GB ; name = GRID V100D-32Q                          
2021-02-01 01:04:41 | INFO | fairseq.utils | ***********************CUDA enviroments for all 1 workers***********************
2021-02-01 01:04:41 | INFO | fairseq_cli.train | training on 1 devices (GPUs/TPUs)
2021-02-01 01:04:41 | INFO | fairseq_cli.train | max tokens per GPU = 4096 and max sentences per GPU = None
2021-02-01 01:04:49 | INFO | fairseq.trainer | loaded checkpoint ../../../models/wmt19.de-en.joined-dict.ensemble//model1.pt (epoch 16 @ 0 updates)
2021-02-01 01:04:49 | INFO | fairseq.trainer | loading train data for epoch 1
2021-02-01 01:04:49 | INFO | fairseq.data.data_utils | loaded 93981 examples from: ../../../data-bin/phrase_4_0.5_tag_EMEA/train.de-en.de
2021-02-01 01:04:49 | INFO | fairseq.data.data_utils | loaded 93981 examples from: ../../../data-bin/phrase_4_0.5_tag_EMEA/train.de-en.en
2021-02-01 01:04:49 | INFO | fairseq.tasks.translation | ../../../data-bin/phrase_4_0.5_tag_EMEA train de-en 93981 examples
2021-02-01 01:04:50 | INFO | fairseq_cli.train | begin training epoch 1
2021-02-01 01:04:50 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 64.0
2021-02-01 01:04:50 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 32.0
2021-02-01 01:04:50 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 16.0
2021-02-01 01:04:51 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 8.0
2021-02-01 01:04:51 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 4.0
2021-02-01 01:05:10 | INFO | train_inner | epoch 001:    105 / 324 loss=3.147, nll_loss=1.37, ppl=2.58, wps=19941.2, ups=5.2, wpb=3837, bsz=288.2, num_updates=100, lr=4.375e-06, gnorm=11.643, loss_scale=4, train_wall=19, wall=29
2021-02-01 01:05:29 | INFO | train_inner | epoch 001:    205 / 324 loss=2.518, nll_loss=0.689, ppl=1.61, wps=19850.7, ups=5.16, wpb=3847.5, bsz=287.2, num_updates=200, lr=8.75e-06, gnorm=1.646, loss_scale=4, train_wall=19, wall=49
2021-02-01 01:05:49 | INFO | train_inner | epoch 001:    305 / 324 loss=2.417, nll_loss=0.586, ppl=1.5, wps=19929, ups=5.2, wpb=3835.6, bsz=295.6, num_updates=300, lr=1.3125e-05, gnorm=1.402, loss_scale=4, train_wall=19, wall=68
2021-02-01 01:05:52 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:05:53 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-02-01 01:05:53 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:05:54 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 01:05:54 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:05:55 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy A rapid improvement in blood glucose control may be associated with symptoms that are known as acute painful neuropathy and are usually reversible.
2021-02-01 01:05:55 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:05:57 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid was studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1 954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a study with 182 patients). In the studies, Actrapid was compared to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c), which indicates how well the blood sugar is regulated. What benefit did Actrapid show in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with Actrapid.
2021-02-01 01:05:57 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:05:57 | INFO | valid | epoch 001 | valid on 'valid' subset | loss 3.706 | nll_loss 1.972 | ppl 3.92 | bleu 38.5 | wps 875.9 | wpb 1083 | bsz 37.8 | num_updates 319
2021-02-01 01:05:57 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:06:15 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_best.pt (epoch 1 @ 319 updates, score 3.706) (writing took 18.104994538240135 seconds)
2021-02-01 01:06:15 | INFO | fairseq_cli.train | end of epoch 1 (average epoch stats below)
2021-02-01 01:06:15 | INFO | train | epoch 001 | loss 2.679 | nll_loss 0.867 | ppl 1.82 | wps 14472.7 | ups 3.77 | wpb 3838.1 | bsz 289.9 | num_updates 319 | lr 1.39562e-05 | gnorm 4.682 | loss_scale 4 | train_wall 62 | wall 95
2021-02-01 01:06:15 | INFO | fairseq_cli.train | begin training epoch 1
2021-02-01 01:06:31 | INFO | train_inner | epoch 002:     81 / 324 loss=2.407, nll_loss=0.579, ppl=1.49, wps=9033, ups=2.36, wpb=3821.6, bsz=285.6, num_updates=400, lr=1.75e-05, gnorm=1.212, loss_scale=4, train_wall=19, wall=110
2021-02-01 01:06:50 | INFO | train_inner | epoch 002:    181 / 324 loss=2.303, nll_loss=0.465, ppl=1.38, wps=20020, ups=5.16, wpb=3877.8, bsz=297, num_updates=500, lr=2.1875e-05, gnorm=1.077, loss_scale=4, train_wall=19, wall=130
2021-02-01 01:07:10 | INFO | train_inner | epoch 002:    281 / 324 loss=2.267, nll_loss=0.427, ppl=1.34, wps=19636.2, ups=5.16, wpb=3802.6, bsz=284, num_updates=600, lr=2.625e-05, gnorm=0.823, loss_scale=4, train_wall=19, wall=149
2021-02-01 01:07:18 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:07:18 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-02-01 01:07:18 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:07:19 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 01:07:19 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:07:20 | INFO | fairseq.tasks.translation | example hypothesis: Nervous disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-02-01 01:07:20 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:07:22 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid was investigated in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a trial with 182 patients). In the trials, Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well glucose is controlled. What benefit has Actrapid shown in these trials? Concentrations of HbA1c remained relatively stable during the 6-month treatment with Actrapid.
2021-02-01 01:07:22 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:07:22 | INFO | valid | epoch 002 | valid on 'valid' subset | loss 3.624 | nll_loss 1.872 | ppl 3.66 | bleu 41.04 | wps 921.7 | wpb 1083 | bsz 37.8 | num_updates 643 | best_loss 3.624
2021-02-01 01:07:22 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:07:41 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_best.pt (epoch 2 @ 643 updates, score 3.624) (writing took 18.102803017944098 seconds)
2021-02-01 01:07:41 | INFO | fairseq_cli.train | end of epoch 2 (average epoch stats below)
2021-02-01 01:07:41 | INFO | train | epoch 002 | loss 2.304 | nll_loss 0.467 | ppl 1.38 | wps 14579 | ups 3.8 | wpb 3838.4 | bsz 290.1 | num_updates 643 | lr 2.81312e-05 | gnorm 0.994 | loss_scale 4 | train_wall 62 | wall 180
2021-02-01 01:07:41 | INFO | fairseq_cli.train | begin training epoch 2
2021-02-01 01:07:52 | INFO | train_inner | epoch 003:     57 / 324 loss=2.21, nll_loss=0.365, ppl=1.29, wps=9187.6, ups=2.38, wpb=3858.5, bsz=300.9, num_updates=700, lr=3.0625e-05, gnorm=0.816, loss_scale=4, train_wall=19, wall=191
2021-02-01 01:08:11 | INFO | train_inner | epoch 003:    157 / 324 loss=2.248, nll_loss=0.405, ppl=1.32, wps=19577.2, ups=5.22, wpb=3747.2, bsz=276.1, num_updates=800, lr=3.5e-05, gnorm=0.983, loss_scale=4, train_wall=19, wall=210
2021-02-01 01:08:30 | INFO | train_inner | epoch 003:    257 / 324 loss=2.192, nll_loss=0.345, ppl=1.27, wps=20068, ups=5.14, wpb=3907.6, bsz=295.9, num_updates=900, lr=3.9375e-05, gnorm=0.838, loss_scale=4, train_wall=19, wall=230
2021-02-01 01:08:43 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:08:44 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-02-01 01:08:44 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:08:45 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 01:08:45 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:08:46 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-02-01 01:08:46 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:08:48 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial with 182 patients). UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates glycaemic control. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-02-01 01:08:48 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:08:48 | INFO | valid | epoch 003 | valid on 'valid' subset | loss 3.667 | nll_loss 1.936 | ppl 3.83 | bleu 42.96 | wps 858.3 | wpb 1083 | bsz 37.8 | num_updates 967 | best_loss 3.624
2021-02-01 01:08:48 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:08:58 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_last.pt (epoch 3 @ 967 updates, score 3.667) (writing took 9.501946005038917 seconds)
2021-02-01 01:08:58 | INFO | fairseq_cli.train | end of epoch 3 (average epoch stats below)
2021-02-01 01:08:58 | INFO | train | epoch 003 | loss 2.214 | nll_loss 0.368 | ppl 1.29 | wps 16149.7 | ups 4.21 | wpb 3838.4 | bsz 290.1 | num_updates 967 | lr 4.23062e-05 | gnorm 0.888 | loss_scale 4 | train_wall 62 | wall 257
2021-02-01 01:08:58 | INFO | fairseq_cli.train | begin training epoch 3
2021-02-01 01:09:04 | INFO | train_inner | epoch 004:     33 / 324 loss=2.199, nll_loss=0.353, ppl=1.28, wps=11368.3, ups=2.96, wpb=3838.4, bsz=292.1, num_updates=1000, lr=4.375e-05, gnorm=0.864, loss_scale=4, train_wall=19, wall=263
2021-02-01 01:09:23 | INFO | train_inner | epoch 004:    133 / 324 loss=2.149, nll_loss=0.297, ppl=1.23, wps=20022.2, ups=5.16, wpb=3882.5, bsz=293.1, num_updates=1100, lr=4.8125e-05, gnorm=0.667, loss_scale=4, train_wall=19, wall=283
2021-02-01 01:09:43 | INFO | train_inner | epoch 004:    233 / 324 loss=2.153, nll_loss=0.302, ppl=1.23, wps=19859.5, ups=5.19, wpb=3823.5, bsz=287.2, num_updates=1200, lr=5.25e-05, gnorm=0.762, loss_scale=4, train_wall=19, wall=302
2021-02-01 01:10:00 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:10:01 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-02-01 01:10:01 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:10:02 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-02-01 01:10:02 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:10:03 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-02-01 01:10:03 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:10:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP The trials compared Actrapid to an analogue of human insulin (insulin Aspart) by measuring in blood for six months the concentration of a substance known as glycosylated haemoglobin (HbA1c), which indicates how well glycaemic control UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid has shown in these trials UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c have remained relatively stable during 6 months of treatment with Actrapid.
2021-02-01 01:10:05 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:10:05 | INFO | valid | epoch 004 | valid on 'valid' subset | loss 3.795 | nll_loss 2.093 | ppl 4.27 | bleu 41.71 | wps 845.1 | wpb 1083 | bsz 37.8 | num_updates 1291 | best_loss 3.624
2021-02-01 01:10:05 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:10:11 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_last.pt (epoch 4 @ 1291 updates, score 3.795) (writing took 5.489136496558785 seconds)
2021-02-01 01:10:11 | INFO | fairseq_cli.train | end of epoch 4 (average epoch stats below)
2021-02-01 01:10:11 | INFO | train | epoch 004 | loss 2.155 | nll_loss 0.303 | ppl 1.23 | wps 17027.9 | ups 4.44 | wpb 3838.4 | bsz 290.1 | num_updates 1291 | lr 5.64813e-05 | gnorm 0.752 | loss_scale 4 | train_wall 62 | wall 330
2021-02-01 01:10:11 | INFO | fairseq_cli.train | begin training epoch 4
2021-02-01 01:10:12 | INFO | train_inner | epoch 005:      9 / 324 loss=2.147, nll_loss=0.295, ppl=1.23, wps=12851.5, ups=3.36, wpb=3825.8, bsz=287.2, num_updates=1300, lr=5.6875e-05, gnorm=0.792, loss_scale=4, train_wall=19, wall=332
2021-02-01 01:10:32 | INFO | train_inner | epoch 005:    109 / 324 loss=2.12, nll_loss=0.265, ppl=1.2, wps=19867.5, ups=5.2, wpb=3819.5, bsz=285.3, num_updates=1400, lr=6.125e-05, gnorm=0.652, loss_scale=4, train_wall=19, wall=351
2021-02-01 01:10:51 | INFO | train_inner | epoch 005:    209 / 324 loss=2.104, nll_loss=0.248, ppl=1.19, wps=19863.9, ups=5.17, wpb=3842, bsz=293.2, num_updates=1500, lr=6.5625e-05, gnorm=0.649, loss_scale=4, train_wall=19, wall=370
2021-02-01 01:11:10 | INFO | train_inner | epoch 005:    309 / 324 loss=2.132, nll_loss=0.279, ppl=1.21, wps=19904.6, ups=5.15, wpb=3864.3, bsz=293.6, num_updates=1600, lr=7e-05, gnorm=0.721, loss_scale=4, train_wall=19, wall=390
2021-02-01 01:11:13 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:11:14 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-02-01 01:11:14 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:11:15 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is a fast-acting insulin and can be used together with long-acting insulin products.
2021-02-01 01:11:15 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:11:15 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may result in symptoms known as acute painful neuropathy, which is usually reversible.
2021-02-01 01:11:15 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:11:18 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was evaluated in type 1 diabetes patients, where the pancreas cannot produce insulin (two trials with 1,954 patients), and in type 2 diabetes patients, where the body cannot effectively process insulin (a study of 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP The trials compared Actrapide to a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well controlled the blood glucose is. UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6-month treatment with Actrapid.
2021-02-01 01:11:18 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:11:18 | INFO | valid | epoch 005 | valid on 'valid' subset | loss 3.912 | nll_loss 2.22 | ppl 4.66 | bleu 42.94 | wps 956.3 | wpb 1083 | bsz 37.8 | num_updates 1615 | best_loss 3.624
2021-02-01 01:11:18 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:11:24 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_last.pt (epoch 5 @ 1615 updates, score 3.912) (writing took 6.604538067243993 seconds)
2021-02-01 01:11:24 | INFO | fairseq_cli.train | end of epoch 5 (average epoch stats below)
2021-02-01 01:11:24 | INFO | train | epoch 005 | loss 2.121 | nll_loss 0.266 | ppl 1.2 | wps 16874.1 | ups 4.4 | wpb 3838.4 | bsz 290.1 | num_updates 1615 | lr 7.06562e-05 | gnorm 0.691 | loss_scale 4 | train_wall 62 | wall 404
2021-02-01 01:11:24 | INFO | fairseq_cli.train | begin training epoch 5
2021-02-01 01:11:41 | INFO | train_inner | epoch 006:     85 / 324 loss=2.112, nll_loss=0.257, ppl=1.19, wps=12498.7, ups=3.29, wpb=3801.8, bsz=285.8, num_updates=1700, lr=7.4375e-05, gnorm=0.622, loss_scale=4, train_wall=19, wall=420
2021-02-01 01:12:00 | INFO | train_inner | epoch 006:    185 / 324 loss=2.093, nll_loss=0.236, ppl=1.18, wps=20013.1, ups=5.15, wpb=3883.1, bsz=295.1, num_updates=1800, lr=7.875e-05, gnorm=0.507, loss_scale=4, train_wall=19, wall=440
2021-02-01 01:12:19 | INFO | train_inner | epoch 006:    285 / 324 loss=2.116, nll_loss=0.262, ppl=1.2, wps=19622.5, ups=5.23, wpb=3754, bsz=282.7, num_updates=1900, lr=8.3125e-05, gnorm=0.641, loss_scale=4, train_wall=19, wall=459
2021-02-01 01:12:27 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:12:28 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-02-01 01:12:28 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:12:28 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid is a fast-acting insulin and can be used concomitantly with long-acting insulin UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:12:28 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:12:29 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy and is usually reversible.
2021-02-01 01:12:29 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:12:31 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, where the pancreas cannot produce insulin (two studies with 1,954 patients), and in patients with type 2 diabetes, where the body cannot effectively process insulin (a study of 182 patients). UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (insulin Aspart) by measured levels of a substance in the blood called glycosylated haemoglobin (HbA1c) that indicates how well the blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP concentrations of HbA1c remained relatively stable during 6-month treatment with Actrapid.
2021-02-01 01:12:31 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:12:32 | INFO | valid | epoch 006 | valid on 'valid' subset | loss 4.048 | nll_loss 2.393 | ppl 5.25 | bleu 41.84 | wps 929.7 | wpb 1083 | bsz 37.8 | num_updates 1939 | best_loss 3.624
2021-02-01 01:12:32 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:12:38 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_last.pt (epoch 6 @ 1939 updates, score 4.048) (writing took 6.672464306466281 seconds)
2021-02-01 01:12:38 | INFO | fairseq_cli.train | end of epoch 6 (average epoch stats below)
2021-02-01 01:12:38 | INFO | train | epoch 006 | loss 2.1 | nll_loss 0.244 | ppl 1.18 | wps 16838.7 | ups 4.39 | wpb 3838.4 | bsz 290.1 | num_updates 1939 | lr 8.48312e-05 | gnorm 0.566 | loss_scale 4 | train_wall 62 | wall 478
2021-02-01 01:12:38 | INFO | fairseq_cli.train | begin training epoch 6
2021-02-01 01:12:50 | INFO | train_inner | epoch 007:     61 / 324 loss=2.086, nll_loss=0.229, ppl=1.17, wps=12702.2, ups=3.26, wpb=3900.1, bsz=293.1, num_updates=2000, lr=8.75e-05, gnorm=0.636, loss_scale=4, train_wall=19, wall=490
2021-02-01 01:13:09 | INFO | train_inner | epoch 007:    161 / 324 loss=2.087, nll_loss=0.231, ppl=1.17, wps=19838, ups=5.16, wpb=3843.6, bsz=292.8, num_updates=2100, lr=9.1875e-05, gnorm=0.599, loss_scale=4, train_wall=19, wall=509
2021-02-01 01:13:29 | INFO | train_inner | epoch 007:    261 / 324 loss=2.095, nll_loss=0.238, ppl=1.18, wps=19799.4, ups=5.18, wpb=3821.8, bsz=281.1, num_updates=2200, lr=9.625e-05, gnorm=0.596, loss_scale=4, train_wall=19, wall=528
2021-02-01 01:13:41 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:13:41 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 01:13:41 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:13:42 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-02-01 01:13:42 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:13:43 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glucose control may be associated with symptoms called acute painful neuropathy, which are usually reversible.
2021-02-01 01:13:43 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:13:45 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was evaluated in type 1 diabetes in which the pancreas cannot produce insulin (two studies involving 1,954 patients), and in type 2 diabetes in which the body cannot effectively process insulin (a trial involving 182 patients). UNKNOWNTOKENINHYP Actrapide was compared to a human insulin analogue (insulin Aspart) by measuring the concentration in blood of a substance called glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit did Actrapid show in these trials? UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of Actrapid treatment.
2021-02-01 01:13:45 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:13:45 | INFO | valid | epoch 007 | valid on 'valid' subset | loss 4.222 | nll_loss 2.602 | ppl 6.07 | bleu 40.4 | wps 931.9 | wpb 1083 | bsz 37.8 | num_updates 2263 | best_loss 3.624
2021-02-01 01:13:45 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:13:52 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_last.pt (epoch 7 @ 2263 updates, score 4.222) (writing took 6.761618243530393 seconds)
2021-02-01 01:13:52 | INFO | fairseq_cli.train | end of epoch 7 (average epoch stats below)
2021-02-01 01:13:52 | INFO | train | epoch 007 | loss 2.089 | nll_loss 0.232 | ppl 1.17 | wps 16804.2 | ups 4.38 | wpb 3838.4 | bsz 290.1 | num_updates 2263 | lr 9.90062e-05 | gnorm 0.595 | loss_scale 4 | train_wall 62 | wall 552
2021-02-01 01:13:52 | INFO | fairseq_cli.train | begin training epoch 7
2021-02-01 01:13:59 | INFO | train_inner | epoch 008:     37 / 324 loss=2.079, nll_loss=0.223, ppl=1.17, wps=12542.7, ups=3.26, wpb=3846, bsz=299.2, num_updates=2300, lr=0.000100625, gnorm=0.472, loss_scale=4, train_wall=19, wall=559
2021-02-01 01:14:19 | INFO | train_inner | epoch 008:    137 / 324 loss=2.087, nll_loss=0.232, ppl=1.17, wps=20011, ups=5.17, wpb=3869.5, bsz=298.5, num_updates=2400, lr=0.000105, gnorm=0.6, loss_scale=4, train_wall=19, wall=578
2021-02-01 01:14:38 | INFO | train_inner | epoch 008:    237 / 324 loss=2.084, nll_loss=0.227, ppl=1.17, wps=19716.2, ups=5.18, wpb=3803.2, bsz=282.7, num_updates=2500, lr=0.000109375, gnorm=0.696, loss_scale=4, train_wall=19, wall=598
2021-02-01 01:14:55 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:14:55 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-02-01 01:14:55 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:14:56 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is a fast-acting insulin and can be used together with long-acting insulin products.
2021-02-01 01:14:56 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:14:57 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP acute pain neuropathy UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP is usually reversible.
2021-02-01 01:14:57 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:15:01 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was evaluated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two studies with 1,954 patients), and in patients with type 2 diabetes in whom the body cannot process insulin. UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring the concentration of a substance called glycosylated haemoglobin (HbA1c) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit did Actrapid show in these trials UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP concentrations of HbA1c during 6-month treatment with Actrapid UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:15:01 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:15:01 | INFO | valid | epoch 008 | valid on 'valid' subset | loss 4.521 | nll_loss 2.935 | ppl 7.65 | bleu 34.89 | wps 651.7 | wpb 1083 | bsz 37.8 | num_updates 2587 | best_loss 3.624
2021-02-01 01:15:01 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:15:08 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_last.pt (epoch 8 @ 2587 updates, score 4.521) (writing took 6.522122249007225 seconds)
2021-02-01 01:15:08 | INFO | fairseq_cli.train | end of epoch 8 (average epoch stats below)
2021-02-01 01:15:08 | INFO | train | epoch 008 | loss 2.081 | nll_loss 0.225 | ppl 1.17 | wps 16501.5 | ups 4.3 | wpb 3838.4 | bsz 290.1 | num_updates 2587 | lr 0.000113181 | gnorm 0.587 | loss_scale 4 | train_wall 62 | wall 627
2021-02-01 01:15:08 | INFO | fairseq_cli.train | begin training epoch 8
2021-02-01 01:15:10 | INFO | train_inner | epoch 009:     13 / 324 loss=2.072, nll_loss=0.214, ppl=1.16, wps=12017.7, ups=3.11, wpb=3859.1, bsz=289.5, num_updates=2600, lr=0.00011375, gnorm=0.503, loss_scale=4, train_wall=19, wall=630
2021-02-01 01:15:29 | INFO | train_inner | epoch 009:    113 / 324 loss=2.081, nll_loss=0.225, ppl=1.17, wps=19969.4, ups=5.18, wpb=3851.5, bsz=292.5, num_updates=2700, lr=0.000118125, gnorm=0.601, loss_scale=4, train_wall=19, wall=649
2021-02-01 01:15:49 | INFO | train_inner | epoch 009:    213 / 324 loss=2.067, nll_loss=0.209, ppl=1.16, wps=19705.5, ups=5.17, wpb=3812.8, bsz=281.9, num_updates=2800, lr=0.0001225, gnorm=0.518, loss_scale=4, train_wall=19, wall=668
2021-02-01 01:16:08 | INFO | train_inner | epoch 009:    313 / 324 loss=2.081, nll_loss=0.227, ppl=1.17, wps=19913.2, ups=5.19, wpb=3837.8, bsz=294.3, num_updates=2900, lr=0.000126875, gnorm=0.483, loss_scale=4, train_wall=19, wall=688
2021-02-01 01:16:10 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:16:11 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP apide contains metacresol, which may cause allergic reactions.
2021-02-01 01:16:11 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:16:11 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide is a fast-acting insulin and can be used concomitantly with long-acting insulin medicines.
2021-02-01 01:16:11 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:16:12 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemia may be associated with symptoms called acute pain neuropathy and are usually reversible.
2021-02-01 01:16:12 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:16:15 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP apide was evaluated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes. Actrapide was compared with a human insulin analogue (insulin Aspart) by maintaining levels of a substance called glycosylated haemoglobin (HbA1c) which indicates how well blood glucose is. What benefit did Actrapide show in these trials? Concentrations of HbA1c were relatively stable during 6-month treatment with Actrapide. Actrapide did not show UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP HbA1c UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP
2021-02-01 01:16:15 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:16:15 | INFO | valid | epoch 009 | valid on 'valid' subset | loss 4.548 | nll_loss 2.972 | ppl 7.85 | bleu 36.02 | wps 959.2 | wpb 1083 | bsz 37.8 | num_updates 2911 | best_loss 3.624
2021-02-01 01:16:15 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:16:21 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_last.pt (epoch 9 @ 2911 updates, score 4.548) (writing took 6.68538570869714 seconds)
2021-02-01 01:16:21 | INFO | fairseq_cli.train | end of epoch 9 (average epoch stats below)
2021-02-01 01:16:21 | INFO | train | epoch 009 | loss 2.076 | nll_loss 0.22 | ppl 1.16 | wps 16870 | ups 4.4 | wpb 3838.4 | bsz 290.1 | num_updates 2911 | lr 0.000127356 | gnorm 0.532 | loss_scale 4 | train_wall 62 | wall 701
2021-02-01 01:16:21 | INFO | fairseq_cli.train | begin training epoch 9
2021-02-01 01:16:39 | INFO | train_inner | epoch 010:     89 / 324 loss=2.067, nll_loss=0.211, ppl=1.16, wps=12618.8, ups=3.28, wpb=3850.2, bsz=289.4, num_updates=3000, lr=0.00013125, gnorm=0.515, loss_scale=4, train_wall=19, wall=718
2021-02-01 01:16:58 | INFO | train_inner | epoch 010:    189 / 324 loss=2.073, nll_loss=0.217, ppl=1.16, wps=19861, ups=5.18, wpb=3835.8, bsz=294.6, num_updates=3100, lr=0.000135625, gnorm=0.537, loss_scale=4, train_wall=19, wall=737
2021-02-01 01:17:17 | INFO | train_inner | epoch 010:    289 / 324 loss=2.074, nll_loss=0.218, ppl=1.16, wps=19854.1, ups=5.17, wpb=3842.9, bsz=287.8, num_updates=3200, lr=0.00014, gnorm=0.572, loss_scale=4, train_wall=19, wall=757
2021-02-01 01:17:24 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:17:25 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 01:17:25 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:17:25 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is a fast-acting insulin and can be administered concomitantly with long-acting insulin compounds.
2021-02-01 01:17:25 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:17:26 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with discomfort known as acute pain neuropathy and is usually reversible.
2021-02-01 01:17:26 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:17:28 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP A1c was studied in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes (a trial of 182 patients). Actrapide was compared with a human insulin analogue (insulin aspart) by measuring the concentration of a substance in the blood called glycosylated haemoglobin (HbA1c) that shows how well the blood sugar is controlled. What benefit has Actrapide shown in these trials? Concentrations of HbA1c remain relative stable during 6-month Actrapide treatment.
2021-02-01 01:17:28 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:17:28 | INFO | valid | epoch 010 | valid on 'valid' subset | loss 4.428 | nll_loss 2.839 | ppl 7.16 | bleu 39.65 | wps 962.8 | wpb 1083 | bsz 37.8 | num_updates 3235 | best_loss 3.624
2021-02-01 01:17:28 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:17:35 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_last.pt (epoch 10 @ 3235 updates, score 4.428) (writing took 6.208760977722704 seconds)
2021-02-01 01:17:35 | INFO | fairseq_cli.train | end of epoch 10 (average epoch stats below)
2021-02-01 01:17:35 | INFO | train | epoch 010 | loss 2.073 | nll_loss 0.216 | ppl 1.16 | wps 16969.5 | ups 4.42 | wpb 3838.4 | bsz 290.1 | num_updates 3235 | lr 0.000141531 | gnorm 0.534 | loss_scale 4 | train_wall 62 | wall 774
2021-02-01 01:17:35 | INFO | fairseq_cli.train | begin training epoch 10
2021-02-01 01:17:47 | INFO | train_inner | epoch 011:     65 / 324 loss=2.073, nll_loss=0.217, ppl=1.16, wps=12754, ups=3.34, wpb=3814.5, bsz=287.4, num_updates=3300, lr=0.000144375, gnorm=0.527, loss_scale=4, train_wall=19, wall=787
2021-02-01 01:18:07 | INFO | train_inner | epoch 011:    165 / 324 loss=2.066, nll_loss=0.209, ppl=1.16, wps=19734.3, ups=5.16, wpb=3823.5, bsz=288.6, num_updates=3400, lr=0.00014875, gnorm=0.513, loss_scale=4, train_wall=19, wall=806
2021-02-01 01:18:26 | INFO | train_inner | epoch 011:    265 / 324 loss=2.07, nll_loss=0.215, ppl=1.16, wps=19911.4, ups=5.17, wpb=3849.6, bsz=292.2, num_updates=3500, lr=0.000153125, gnorm=0.473, loss_scale=4, train_wall=19, wall=825
2021-02-01 01:18:37 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:18:38 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP trapide contains metacresol, which may cause allergic reactions.
2021-02-01 01:18:38 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:18:39 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is a fast-acting insulin and can be used with long-acting insulin medicines.
2021-02-01 01:18:39 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:18:39 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood sugar control may be associated with disorders called acute pain neuropathy, usually reversible.
2021-02-01 01:18:39 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:18:41 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Atrapide was evaluated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two studies with 1,954 patients), and in patients with type 2 insulin. Actrapide was compared with a human insulin analogue (insulin aspart) by UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:18:41 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:18:41 | INFO | valid | epoch 011 | valid on 'valid' subset | loss 4.754 | nll_loss 3.199 | ppl 9.18 | bleu 34.16 | wps 1335.7 | wpb 1083 | bsz 37.8 | num_updates 3559 | best_loss 3.624
2021-02-01 01:18:41 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:18:47 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_last.pt (epoch 11 @ 3559 updates, score 4.754) (writing took 6.027677561156452 seconds)
2021-02-01 01:18:47 | INFO | fairseq_cli.train | end of epoch 11 (average epoch stats below)
2021-02-01 01:18:47 | INFO | train | epoch 011 | loss 2.07 | nll_loss 0.214 | ppl 1.16 | wps 17250.9 | ups 4.49 | wpb 3838.4 | bsz 290.1 | num_updates 3559 | lr 0.000155706 | gnorm 0.524 | loss_scale 4 | train_wall 62 | wall 846
2021-02-01 01:18:47 | INFO | fairseq_cli.train | begin training epoch 11
2021-02-01 01:18:55 | INFO | train_inner | epoch 012:     41 / 324 loss=2.075, nll_loss=0.22, ppl=1.16, wps=13387.7, ups=3.48, wpb=3849.8, bsz=292.7, num_updates=3600, lr=0.0001575, gnorm=0.541, loss_scale=4, train_wall=19, wall=854
2021-02-01 01:19:14 | INFO | train_inner | epoch 012:    141 / 324 loss=2.065, nll_loss=0.209, ppl=1.16, wps=19952.2, ups=5.16, wpb=3867.5, bsz=295, num_updates=3700, lr=0.000161875, gnorm=0.486, loss_scale=4, train_wall=19, wall=873
2021-02-01 01:19:33 | INFO | train_inner | epoch 012:    241 / 324 loss=2.07, nll_loss=0.216, ppl=1.16, wps=19942.5, ups=5.17, wpb=3854.4, bsz=296.9, num_updates=3800, lr=0.00016625, gnorm=0.734, loss_scale=4, train_wall=19, wall=893
2021-02-01 01:19:49 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:19:50 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 01:19:50 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:19:51 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is a fast-acting insulin and can be added to long-acting insulin compounds.
2021-02-01 01:19:51 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:19:51 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:19:51 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:19:52 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide (two studies with 1,954 patients) and a glycosylated HbA1c) indicating how well Actrapide has UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:19:52 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:19:52 | INFO | valid | epoch 012 | valid on 'valid' subset | loss 5.284 | nll_loss 3.783 | ppl 13.77 | bleu 25.86 | wps 1464 | wpb 1083 | bsz 37.8 | num_updates 3883 | best_loss 3.624
2021-02-01 01:19:52 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:19:59 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_last.pt (epoch 12 @ 3883 updates, score 5.284) (writing took 6.5261191707104445 seconds)
2021-02-01 01:19:59 | INFO | fairseq_cli.train | end of epoch 12 (average epoch stats below)
2021-02-01 01:19:59 | INFO | train | epoch 012 | loss 2.07 | nll_loss 0.214 | ppl 1.16 | wps 17213.3 | ups 4.48 | wpb 3838.4 | bsz 290.1 | num_updates 3883 | lr 0.000169881 | gnorm 0.572 | loss_scale 4 | train_wall 62 | wall 918
2021-02-01 01:19:59 | INFO | fairseq_cli.train | begin training epoch 12
2021-02-01 01:20:02 | INFO | train_inner | epoch 013:     17 / 324 loss=2.079, nll_loss=0.222, ppl=1.17, wps=13153.1, ups=3.45, wpb=3808.1, bsz=278.6, num_updates=3900, lr=0.000170625, gnorm=0.555, loss_scale=4, train_wall=19, wall=922
2021-02-01 01:20:22 | INFO | train_inner | epoch 013:    117 / 324 loss=2.057, nll_loss=0.2, ppl=1.15, wps=19893.4, ups=5.15, wpb=3859.1, bsz=292.7, num_updates=4000, lr=0.000175, gnorm=0.407, loss_scale=4, train_wall=19, wall=941
2021-02-01 01:20:41 | INFO | train_inner | epoch 013:    217 / 324 loss=2.071, nll_loss=0.215, ppl=1.16, wps=19926.8, ups=5.19, wpb=3842.1, bsz=287.9, num_updates=4100, lr=0.000172853, gnorm=0.508, loss_scale=4, train_wall=19, wall=960
2021-02-01 01:21:00 | INFO | train_inner | epoch 013:    317 / 324 loss=2.066, nll_loss=0.209, ppl=1.16, wps=19645.2, ups=5.18, wpb=3794.8, bsz=288.1, num_updates=4200, lr=0.000170783, gnorm=0.62, loss_scale=4, train_wall=19, wall=980
2021-02-01 01:21:02 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:21:02 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-02-01 01:21:02 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:21:03 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is a fast-acting insulin and can be used together with long-acting insulin compounds.
2021-02-01 01:21:03 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:21:04 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with disorders called acute pain neuropathy. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:21:04 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:21:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP in patients with type 1 diabetes in which the blood glucose adjustment. What benefit has Actrapide shown during these trials UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:21:05 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:21:05 | INFO | valid | epoch 013 | valid on 'valid' subset | loss 5.134 | nll_loss 3.631 | ppl 12.39 | bleu 29.8 | wps 1356 | wpb 1083 | bsz 37.8 | num_updates 4207 | best_loss 3.624
2021-02-01 01:21:05 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:21:11 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_last.pt (epoch 13 @ 4207 updates, score 5.134) (writing took 6.063323218375444 seconds)
2021-02-01 01:21:11 | INFO | fairseq_cli.train | end of epoch 13 (average epoch stats below)
2021-02-01 01:21:11 | INFO | train | epoch 013 | loss 2.065 | nll_loss 0.209 | ppl 1.16 | wps 17234.1 | ups 4.49 | wpb 3838.4 | bsz 290.1 | num_updates 4207 | lr 0.00017064 | gnorm 0.512 | loss_scale 4 | train_wall 62 | wall 991
2021-02-01 01:21:11 | INFO | fairseq_cli.train | begin training epoch 13
2021-02-01 01:21:29 | INFO | train_inner | epoch 014:     93 / 324 loss=2.059, nll_loss=0.203, ppl=1.15, wps=13335.5, ups=3.48, wpb=3836.4, bsz=283.7, num_updates=4300, lr=0.000168785, gnorm=0.446, loss_scale=4, train_wall=19, wall=1009
2021-02-01 01:21:48 | INFO | train_inner | epoch 014:    193 / 324 loss=2.062, nll_loss=0.205, ppl=1.15, wps=19591.9, ups=5.16, wpb=3793.2, bsz=283.4, num_updates=4400, lr=0.000166856, gnorm=0.484, loss_scale=4, train_wall=19, wall=1028
2021-02-01 01:22:08 | INFO | train_inner | epoch 014:    293 / 324 loss=2.064, nll_loss=0.21, ppl=1.16, wps=20148.2, ups=5.17, wpb=3895.2, bsz=300.5, num_updates=4500, lr=0.000164992, gnorm=0.569, loss_scale=4, train_wall=19, wall=1047
2021-02-01 01:22:14 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:22:14 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which may cause allergic reactions. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:22:14 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:22:15 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is a fast-acting insulin and can be used together with long-acting insulin compounds. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:22:15 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:22:16 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous disorders Uncommon - Peripheral neuropathy Fast improvement in blood sugar control may result in disorders called hyperpyrexia. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:22:16 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:22:17 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP A1-month treatment with Actrapide (two studies involving hyperpyrexia UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:22:17 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:22:17 | INFO | valid | epoch 014 | valid on 'valid' subset | loss 5.469 | nll_loss 3.998 | ppl 15.98 | bleu 25.55 | wps 1394.6 | wpb 1083 | bsz 37.8 | num_updates 4531 | best_loss 3.624
2021-02-01 01:22:17 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:22:23 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_last.pt (epoch 14 @ 4531 updates, score 5.469) (writing took 5.933726166374981 seconds)
2021-02-01 01:22:23 | INFO | fairseq_cli.train | end of epoch 14 (average epoch stats below)
2021-02-01 01:22:23 | INFO | train | epoch 014 | loss 2.061 | nll_loss 0.206 | ppl 1.15 | wps 17304.6 | ups 4.51 | wpb 3838.4 | bsz 290.1 | num_updates 4531 | lr 0.000164426 | gnorm 0.487 | loss_scale 4 | train_wall 62 | wall 1062
2021-02-01 01:22:23 | INFO | fairseq_cli.train | begin training epoch 14
2021-02-01 01:22:36 | INFO | train_inner | epoch 015:     69 / 324 loss=2.05, nll_loss=0.194, ppl=1.14, wps=13376.2, ups=3.5, wpb=3825.2, bsz=295.8, num_updates=4600, lr=0.000163188, gnorm=0.327, loss_scale=4, train_wall=19, wall=1076
2021-02-01 01:22:56 | INFO | train_inner | epoch 015:    169 / 324 loss=2.063, nll_loss=0.209, ppl=1.16, wps=20089.5, ups=5.17, wpb=3886.1, bsz=295.8, num_updates=4700, lr=0.000161443, gnorm=0.507, loss_scale=4, train_wall=19, wall=1095
2021-02-01 01:23:15 | INFO | train_inner | epoch 015:    269 / 324 loss=2.064, nll_loss=0.208, ppl=1.16, wps=19797.8, ups=5.2, wpb=3810.3, bsz=285, num_updates=4800, lr=0.000159752, gnorm=0.582, loss_scale=4, train_wall=19, wall=1114
2021-02-01 01:23:26 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:23:26 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP apide contains metacresol, which may cause allergic reactions.
2021-02-01 01:23:26 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:23:27 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PRODUCT is a fast-acting insulin and can be used concomitantly. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:23:27 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:23:28 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PRODUCT control may be associated with disorders usually reversible UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PRODUCTS
2021-02-01 01:23:28 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:23:28 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTapide (two studies in which the blood glucose control UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:23:28 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:23:28 | INFO | valid | epoch 015 | valid on 'valid' subset | loss 5.942 | nll_loss 4.549 | ppl 23.41 | bleu 22 | wps 1646.2 | wpb 1083 | bsz 37.8 | num_updates 4855 | best_loss 3.624
2021-02-01 01:23:28 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:23:35 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_last.pt (epoch 15 @ 4855 updates, score 5.942) (writing took 6.608330513350666 seconds)
2021-02-01 01:23:35 | INFO | fairseq_cli.train | end of epoch 15 (average epoch stats below)
2021-02-01 01:23:35 | INFO | train | epoch 015 | loss 2.06 | nll_loss 0.205 | ppl 1.15 | wps 17260.5 | ups 4.5 | wpb 3838.4 | bsz 290.1 | num_updates 4855 | lr 0.000158845 | gnorm 0.48 | loss_scale 4 | train_wall 62 | wall 1134
2021-02-01 01:23:35 | INFO | fairseq_cli.train | begin training epoch 15
2021-02-01 01:23:44 | INFO | train_inner | epoch 016:     45 / 324 loss=2.057, nll_loss=0.2, ppl=1.15, wps=13067.5, ups=3.49, wpb=3747.8, bsz=273.2, num_updates=4900, lr=0.000158114, gnorm=0.468, loss_scale=4, train_wall=19, wall=1143
2021-02-01 01:24:03 | INFO | train_inner | epoch 016:    145 / 324 loss=2.053, nll_loss=0.198, ppl=1.15, wps=20122, ups=5.18, wpb=3886.4, bsz=295.4, num_updates=5000, lr=0.000156525, gnorm=0.406, loss_scale=4, train_wall=19, wall=1162
2021-02-01 01:24:22 | INFO | train_inner | epoch 016:    245 / 324 loss=2.065, nll_loss=0.211, ppl=1.16, wps=20128.1, ups=5.18, wpb=3885.9, bsz=293.7, num_updates=5100, lr=0.000154983, gnorm=0.44, loss_scale=4, train_wall=19, wall=1182
2021-02-01 01:24:38 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:24:38 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP apide contains metacresol, which may cause allergic reactions. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:24:38 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:24:39 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP apide is a fast-acting insulin and can be used together with long-acting insulin. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:24:39 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:24:40 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with discomfort which is usually reversible.
2021-02-01 01:24:40 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:24:41 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTapide in HbA1c (where the blood sugar to 1,954 patients) and Actrapide (6-month treatment with Actrapide). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:24:41 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:24:41 | INFO | valid | epoch 016 | valid on 'valid' subset | loss 5.815 | nll_loss 4.412 | ppl 21.29 | bleu 24.36 | wps 1404.1 | wpb 1083 | bsz 37.8 | num_updates 5179 | best_loss 3.624
2021-02-01 01:24:41 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:24:48 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_last.pt (epoch 16 @ 5179 updates, score 5.815) (writing took 6.863029325380921 seconds)
2021-02-01 01:24:48 | INFO | fairseq_cli.train | end of epoch 16 (average epoch stats below)
2021-02-01 01:24:48 | INFO | train | epoch 016 | loss 2.056 | nll_loss 0.201 | ppl 1.15 | wps 17117.6 | ups 4.46 | wpb 3838.4 | bsz 290.1 | num_updates 5179 | lr 0.000153796 | gnorm 0.441 | loss_scale 4 | train_wall 62 | wall 1207
2021-02-01 01:24:48 | INFO | fairseq_cli.train | begin training epoch 16
2021-02-01 01:24:52 | INFO | train_inner | epoch 017:     21 / 324 loss=2.048, nll_loss=0.193, ppl=1.14, wps=12972.4, ups=3.39, wpb=3830.2, bsz=296.5, num_updates=5200, lr=0.000153485, gnorm=0.422, loss_scale=4, train_wall=19, wall=1211
2021-02-01 01:25:11 | INFO | train_inner | epoch 017:    121 / 324 loss=2.048, nll_loss=0.193, ppl=1.14, wps=20041.6, ups=5.16, wpb=3883.6, bsz=294.6, num_updates=5300, lr=0.00015203, gnorm=0.423, loss_scale=4, train_wall=19, wall=1231
2021-02-01 01:25:30 | INFO | train_inner | epoch 017:    221 / 324 loss=2.06, nll_loss=0.205, ppl=1.15, wps=19860.9, ups=5.19, wpb=3824.2, bsz=284.2, num_updates=5400, lr=0.000150616, gnorm=0.462, loss_scale=4, train_wall=19, wall=1250
2021-02-01 01:25:50 | INFO | train_inner | epoch 017:    321 / 324 loss=2.061, nll_loss=0.207, ppl=1.15, wps=19731.9, ups=5.2, wpb=3796.7, bsz=289.2, num_updates=5500, lr=0.000149241, gnorm=0.486, loss_scale=4, train_wall=19, wall=1269
2021-02-01 01:25:50 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:25:51 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP contains metacresol, which may cause allergic reactions. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:25:51 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:25:52 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP is a fast-acting insulin and can be used concomitantly with long-acting insulin. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:25:52 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:25:53 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with disorders that are usually reversible UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:25:53 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:25:53 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP in type 1 diabetes (a study with 1,954 patients) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:25:53 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:25:53 | INFO | valid | epoch 017 | valid on 'valid' subset | loss 5.9 | nll_loss 4.498 | ppl 22.59 | bleu 21.19 | wps 1448.6 | wpb 1083 | bsz 37.8 | num_updates 5503 | best_loss 3.624
2021-02-01 01:25:53 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:26:00 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_last.pt (epoch 17 @ 5503 updates, score 5.9) (writing took 6.826709941029549 seconds)
2021-02-01 01:26:00 | INFO | fairseq_cli.train | end of epoch 17 (average epoch stats below)
2021-02-01 01:26:00 | INFO | train | epoch 017 | loss 2.055 | nll_loss 0.2 | ppl 1.15 | wps 17119.8 | ups 4.46 | wpb 3838.4 | bsz 290.1 | num_updates 5503 | lr 0.0001492 | gnorm 0.447 | loss_scale 4 | train_wall 62 | wall 1280
2021-02-01 01:26:00 | INFO | fairseq_cli.train | begin training epoch 17
2021-02-01 01:26:19 | INFO | train_inner | epoch 018:     97 / 324 loss=2.048, nll_loss=0.193, ppl=1.14, wps=13177.7, ups=3.39, wpb=3885.5, bsz=294.2, num_updates=5600, lr=0.000147902, gnorm=0.357, loss_scale=4, train_wall=19, wall=1299
2021-02-01 01:26:39 | INFO | train_inner | epoch 018:    197 / 324 loss=2.05, nll_loss=0.195, ppl=1.14, wps=19827.6, ups=5.17, wpb=3835.8, bsz=293, num_updates=5700, lr=0.000146599, gnorm=0.366, loss_scale=4, train_wall=19, wall=1318
2021-02-01 01:26:58 | INFO | train_inner | epoch 018:    297 / 324 loss=2.061, nll_loss=0.206, ppl=1.15, wps=19753, ups=5.19, wpb=3807.6, bsz=287.1, num_updates=5800, lr=0.00014533, gnorm=0.459, loss_scale=4, train_wall=19, wall=1337
2021-02-01 01:27:03 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:27:04 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP contains metacresol, which may cause allergic reactions. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:27:04 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:27:04 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP is fast-acting insulin and can be used concomitantly with long-acting UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:27:04 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:27:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Uncommon - Peripheral neuropathy may be associated with conditions called acute pain neuropathy. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:27:05 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:27:06 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP in patients with type 1 diabetes with Actrapide analogues (HbA1c) UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:27:06 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:27:06 | INFO | valid | epoch 018 | valid on 'valid' subset | loss 5.992 | nll_loss 4.598 | ppl 24.22 | bleu 19.88 | wps 1576.8 | wpb 1083 | bsz 37.8 | num_updates 5827 | best_loss 3.624
2021-02-01 01:27:06 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:27:12 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_last.pt (epoch 18 @ 5827 updates, score 5.992) (writing took 6.390093791298568 seconds)
2021-02-01 01:27:12 | INFO | fairseq_cli.train | end of epoch 18 (average epoch stats below)
2021-02-01 01:27:12 | INFO | train | epoch 018 | loss 2.052 | nll_loss 0.197 | ppl 1.15 | wps 17269.2 | ups 4.5 | wpb 3838.4 | bsz 290.1 | num_updates 5827 | lr 0.000144992 | gnorm 0.382 | loss_scale 4 | train_wall 62 | wall 1352
2021-02-01 01:27:12 | INFO | fairseq_cli.train | begin training epoch 18
2021-02-01 01:27:26 | INFO | train_inner | epoch 019:     73 / 324 loss=2.044, nll_loss=0.188, ppl=1.14, wps=13192.4, ups=3.49, wpb=3776.3, bsz=281.6, num_updates=5900, lr=0.000144093, gnorm=0.278, loss_scale=4, train_wall=19, wall=1366
2021-02-01 01:27:46 | INFO | train_inner | epoch 019:    173 / 324 loss=2.051, nll_loss=0.198, ppl=1.15, wps=20070.1, ups=5.17, wpb=3880, bsz=296.2, num_updates=6000, lr=0.000142887, gnorm=0.385, loss_scale=4, train_wall=19, wall=1385
2021-02-01 01:28:05 | INFO | train_inner | epoch 019:    273 / 324 loss=2.051, nll_loss=0.198, ppl=1.15, wps=20017.6, ups=5.18, wpb=3864.8, bsz=296.1, num_updates=6100, lr=0.000141711, gnorm=0.406, loss_scale=4, train_wall=19, wall=1404
2021-02-01 01:28:15 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:28:15 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP contains metacresol, which may cause allergic reactions. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:28:15 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:28:16 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP is fast-acting insulin and can be used together with long-acting insulin. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:28:16 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:28:17 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with disorders called acute pain UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:28:17 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:28:18 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP in type 1 diabetes (Hbapide). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:28:18 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:28:18 | INFO | valid | epoch 019 | valid on 'valid' subset | loss 6.185 | nll_loss 4.806 | ppl 27.97 | bleu 25.96 | wps 1401.6 | wpb 1083 | bsz 37.8 | num_updates 6151 | best_loss 3.624
2021-02-01 01:28:18 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:28:25 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_last.pt (epoch 19 @ 6151 updates, score 6.185) (writing took 6.659493579529226 seconds)
2021-02-01 01:28:25 | INFO | fairseq_cli.train | end of epoch 19 (average epoch stats below)
2021-02-01 01:28:25 | INFO | train | epoch 019 | loss 2.051 | nll_loss 0.197 | ppl 1.15 | wps 17163.8 | ups 4.47 | wpb 3838.4 | bsz 290.1 | num_updates 6151 | lr 0.000141122 | gnorm 0.384 | loss_scale 4 | train_wall 62 | wall 1424
2021-02-01 01:28:25 | INFO | fairseq_cli.train | begin training epoch 19
2021-02-01 01:28:34 | INFO | train_inner | epoch 020:     49 / 324 loss=2.049, nll_loss=0.194, ppl=1.14, wps=13116.6, ups=3.41, wpb=3846.7, bsz=278.7, num_updates=6200, lr=0.000140563, gnorm=0.417, loss_scale=4, train_wall=19, wall=1434
2021-02-01 01:28:54 | INFO | train_inner | epoch 020:    149 / 324 loss=2.049, nll_loss=0.196, ppl=1.15, wps=19999, ups=5.17, wpb=3865.8, bsz=296.2, num_updates=6300, lr=0.000139443, gnorm=0.329, loss_scale=4, train_wall=19, wall=1453
2021-02-01 01:29:13 | INFO | train_inner | epoch 020:    249 / 324 loss=2.052, nll_loss=0.199, ppl=1.15, wps=19793.8, ups=5.18, wpb=3824, bsz=294.6, num_updates=6400, lr=0.00013835, gnorm=0.392, loss_scale=4, train_wall=19, wall=1472
2021-02-01 01:29:27 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 01:29:28 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP contains metacresol, which may cause allergic reactions. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:29:28 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 01:29:29 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP is a fast-acting insulin and can be used concomitantly with long-acting insulin. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:29:29 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 01:29:30 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP disorders known as acute pain neuropathy Fast improvement in blood control UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:29:30 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 01:29:30 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP in 6-month treatment with Actrapide (HbA1c) indicating how well the blood sugar UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP PTUNKNOWNTOKENINHYP
2021-02-01 01:29:30 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 01:29:30 | INFO | valid | epoch 020 | valid on 'valid' subset | loss 6.177 | nll_loss 4.825 | ppl 28.34 | bleu 23.26 | wps 1599.8 | wpb 1083 | bsz 37.8 | num_updates 6475 | best_loss 3.624
2021-02-01 01:29:30 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 01:29:36 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_7/checkpoint_last.pt (epoch 20 @ 6475 updates, score 6.177) (writing took 5.834052830003202 seconds)
2021-02-01 01:29:36 | INFO | fairseq_cli.train | end of epoch 20 (average epoch stats below)
2021-02-01 01:29:36 | INFO | train | epoch 020 | loss 2.049 | nll_loss 0.195 | ppl 1.14 | wps 17420.7 | ups 4.54 | wpb 3838.4 | bsz 290.1 | num_updates 6475 | lr 0.000137546 | gnorm 0.357 | loss_scale 4 | train_wall 62 | wall 1496
2021-02-01 01:29:36 | INFO | fairseq_cli.train | done training in 1486.4 seconds


###############################################################################
Peregrine Cluster
Job 17762803 for user 's3475743'
Finished at: Mon Feb  1 01:29:39 CET 2021

Job details:
============

Job ID              : 17762803
Name                : EMEA_p_7
User                : s3475743
Partition           : gpu
Nodes               : pg-gpu30
Number of Nodes     : 1
Cores               : 12
State               : COMPLETED
Submit              : 2021-02-01T01:03:27
Start               : 2021-02-01T01:04:27
End                 : 2021-02-01T01:29:39
Reserved walltime   : 23:55:00
Used walltime       : 00:25:12
Used CPU time       : 00:27:07 (efficiency:  8.97%)
% User (Computation): 68.37%
% System (I/O)      : 31.63%
Mem reserved        : 32G/node
Max Mem used        : 5.61G (pg-gpu30)
Max Disk Write      : 40.96K (pg-gpu30)
Max Disk Read       : 2.30M (pg-gpu30)
Average GPU usage   : 75.8% (pg-gpu30)


Acknowledgements:
=================

Please see this page for information about acknowledging Peregrine in your publications:

https://wiki.hpc.rug.nl/peregrine/introduction/scientific_output

################################################################################
